MedPath

An Implementation Trial to Improve Access to Pulmonary Rehabilitation in People With COPD

Not Applicable
Recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Behavioral: Choice of home-based or centre-based pulmonary rehabilitation
Behavioral: Centre-based pulmonary rehabilitation
Registration Number
NCT04217330
Lead Sponsor
Monash University
Brief Summary

People with chronic obstructive pulmonary disease (COPD) experience distressing breathlessness and high health care utilisation. There is compelling evidence that pulmonary rehabilitation improves symptoms and reduces hospitalisation, but is delivered to \<10% of patients who would benefit. The investigators developed a low cost model of pulmonary rehabilitation that can be delivered entirely at home. The HomeBase model had equivalent outcomes to centre-based pulmonary rehabilitation in a phase II efficacy trial, with higher completion rates. The investigators hypothesise that a patient centred model offering a choice between home or centre-based pulmonary rehabilitation may increase program completion rates, with improved outcomes for patients and the health system.

This is a cluster randomised implementation trial investigating whether offering a choice of home or centre-based pulmonary rehabilitation can reduce hospitalisation, improve pulmonary rehabilitation completion and enhance patient outcomes in people with COPD. 14 pulmonary rehabilitation programs located across Australia will each recruit 35 people with COPD. Intervention centres: People with COPD will be offered the choice of centre-based pulmonary rehabilitation or the HomeBase model. Comparison centres: Only the existing centre-based model will be offered. The primary outcome is all cause, non-elective hospitalisation at 12 months. Other outcomes are symptoms, exercise capacity and quality of life at 8 weeks and 12 months; and health care costs at 12 months for full economic evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
490
Inclusion Criteria

Not provided

Exclusion Criteria
  • Attended pulmonary rehabilitation within 1 year
  • Comorbidities which preclude exercise training.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionChoice of home-based or centre-based pulmonary rehabilitationPulmonary rehabilitation programs assigned to the intervention group will offer eligible participants the choice of participating in an 8-week program of either home-based pulmonary rehabilitation or traditional centre-based pulmonary rehabilitation.
ControlCentre-based pulmonary rehabilitationPulmonary rehabilitation programs assigned to the control group will offer eligible participants the opportunity to participate in an 8-week centre-based pulmonary rehabilitation program, as per current practice.
Primary Outcome Measures
NameTimeMethod
All cause, non-elective hospitalisation12 months after completing pulmonary rehabilitation

The number of participants hospitalised at least once will be compared between groups

Secondary Outcome Measures
NameTimeMethod
Change in 6-minute walk distanceEnd of rehabilitation and 12 months later

Distance walked in 6 minutes

Program completionEnd of rehabilitation

The number of participants who complete their allocated rehabilitation program (attend at least 70% of planned sessions).

Change in chronic respiratory disease questionnaire total and domain scoresEnd of rehabilitation and 12 months later

Disease-specific health-related quality of life measure; scores range 1-7, higher scores indicate better health-related quality of life

EQ-5D-5LEnd of rehabilitation and 12 months later

Generic health-related quality of life measure to inform economic analysis; 5 dimensions each scored 1-5 with lower values indicating better health-related quality of life

Change in objectively measured physical activityEnd of rehabilitation and 12 months later

Objective measure of physical activity using the actigraph

Health care costs12 months following pulmonary rehabilitation completion

Health care costs in Australian dollars will be calculated using health care utilisation data including hospitalisation, primary care visits and medication use

Change in dyspnoea-12End of rehabilitation and 12 months later

Global measure of breathlessness; total scores range from 0 to 36, with higher scores corresponding to greater severity of dyspnoea

Trial Locations

Locations (11)

Prince of Wales Hospital

🇦🇺

Sydney, New South Wales, Australia

Royal Prince Alfred Hospital

🇦🇺

Sydney, New South Wales, Australia

Mount Druitt Hospital

🇦🇺

Sydney, New South Wales, Australia

Prince Charles Hospital

🇦🇺

Brisbane, Queensland, Australia

Central Adelaide Local Health Network

🇦🇺

Adelaide, South Australia, Australia

Southern Adelaide Local Health Network

🇦🇺

Adelaide, South Australia, Australia

St John of God Frankston Rehabilitation

🇦🇺

Melbourne, Victoria, Australia

Westmead Hospital

🇦🇺

Sydney, New South Wales, Australia

Western Health

🇦🇺

Melbourne, Victoria, Australia

Top End Health Service

🇦🇺

Darwin, Northern Territory, Australia

Peninsula Health

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath